Skip to main content
Top
Published in: World Journal of Surgical Oncology 1/2018

Open Access 01-12-2018 | Research

The diagnostic ureteroscopy before radical nephroureterectomy in upper urinary tract urothelial carcinoma is not associated with higher intravesical recurrence

Authors: Hsiang-Ying Lee, Hsin-Chih Yeh, Wen-Jeng Wu, Jiun-Shiuan He, Chun-Nung Huang, Hung-Lung Ke, Wei-Ming Li, Chien-Feng Li, Ching-Chia Li

Published in: World Journal of Surgical Oncology | Issue 1/2018

Login to get access

Abstract

Background

To clarify if diagnostic ureteroscopy (URS) before radical nephroureterectomy for patients with upper tract urothelial carcinoma (UTUC) will increase the risk of intravesical recurrence.

Methods

From retrospective review of cohort at our institution, 502 patients with UTUC who underwent radical nephroureterectomy with bladder cuff excision were enrolled from 1990 to 2013. Cox proportional hazards model was used to analyze the overall survival (OS), disease-free survival (DFS), metastasis-free survival (MFS), and intravesical recurrence-free survival (IVRFS). The log-rank test was used for comparing survival curves. All potential risk factors were included in the multivariate Cox proportional hazards model to recognize independent predictors. From NHI database, we included patients of UTUC without bladder cancer history using population-based database in Taiwan from 1996 to 2013. In total, 3079 URS and 2634 non-URS patients with UTUC were identified. Univariate and multivariate Cox proportional hazards regressions were performed to measure the risk of IVRFS and all-cause mortality.

Results

From our database, the comparison of clinicopathological characteristics in UTUC patients between with URS biopsy group (URS+) (n = 206, 41%) and without URS biopsy group (URS−) (n = 296, 59%) was insignificantly different excluding surgical method. URS biopsy is not associated with worse OS (p = 0.720), DFS (p = 0.294), MFS (p = 0.808), and IVRFS (p = 0.560) by multivariate analysis. Only bladder cancer history is an independent significant factor to predict IVR (p < 0.001). The same result from NHI database, URS before radical surgery will not increase the risk of IVRFS [adjusted HR 1.136, 95% CI 1.00–1.30; P = 0.059] and OS [adjusted HR 0.919, 95% CI 0.82–1.04; P = 0.164].

Conclusions

Preoperative URS manipulation is not associated with higher risk of IVRFS even in patients without bladder cancer history. Diagnostic URS is feasible to compensate the insufficient information of image in patients with UTUC.
Literature
1.
go back to reference Margulis V, Shariat SF, Matin SF, et al. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer. 2009;115(6):1224–33.CrossRefPubMed Margulis V, Shariat SF, Matin SF, et al. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer. 2009;115(6):1224–33.CrossRefPubMed
2.
go back to reference Verhoest G, Shariat SF, Chromecki TF, et al. Predictive factors of recurrence and survival of upper tract urothelial carcinomas. World J Urol. 2011;29:495–501.CrossRefPubMedPubMedCentral Verhoest G, Shariat SF, Chromecki TF, et al. Predictive factors of recurrence and survival of upper tract urothelial carcinomas. World J Urol. 2011;29:495–501.CrossRefPubMedPubMedCentral
3.
go back to reference Lai MN, Wang SM, Chen PC, et al. Population-based case-control study of Chinese herbal products containing aristolochic acid and urinary tract cancer risk. J Natl Cancer Inst. 2010;102:179–86.CrossRefPubMedPubMedCentral Lai MN, Wang SM, Chen PC, et al. Population-based case-control study of Chinese herbal products containing aristolochic acid and urinary tract cancer risk. J Natl Cancer Inst. 2010;102:179–86.CrossRefPubMedPubMedCentral
4.
go back to reference Li CC, Chang TH, Wu WJ, et al. Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients. Eur Urol. 2008;54:1127–34.CrossRefPubMed Li CC, Chang TH, Wu WJ, et al. Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients. Eur Urol. 2008;54:1127–34.CrossRefPubMed
5.
go back to reference Cutress ML, Stewart GD, Wells-Cole S, et al. Long-term endoscopic management of upper tract urothelial carcinoma: 20-year single-centre experience. BJU Int. 2012;110:1608–17.CrossRefPubMed Cutress ML, Stewart GD, Wells-Cole S, et al. Long-term endoscopic management of upper tract urothelial carcinoma: 20-year single-centre experience. BJU Int. 2012;110:1608–17.CrossRefPubMed
6.
go back to reference Chitale S, Mbakada R, Irving S, et al. Nephroureterectomy for transitional cell carcinoma—the value of pre-operative histology. Ann R Coll Surg Engl. 2008;90:45–50.CrossRefPubMedPubMedCentral Chitale S, Mbakada R, Irving S, et al. Nephroureterectomy for transitional cell carcinoma—the value of pre-operative histology. Ann R Coll Surg Engl. 2008;90:45–50.CrossRefPubMedPubMedCentral
7.
go back to reference Guarnizo E, Pavlovich CP, Seiba M, et al. Ureteroscopic biopsy of upper tract urothelial carcinoma: improved diagnostic accuracy and histopathological considerations using a multi-biopsy approach. J Urol. 2000;163:52–5.CrossRefPubMed Guarnizo E, Pavlovich CP, Seiba M, et al. Ureteroscopic biopsy of upper tract urothelial carcinoma: improved diagnostic accuracy and histopathological considerations using a multi-biopsy approach. J Urol. 2000;163:52–5.CrossRefPubMed
8.
go back to reference Andersen JR, Kristensen JK. Ureteroscopic management of transitional cell tumors. Scand J Urol Nephrol. 1994;28:153–7.CrossRefPubMed Andersen JR, Kristensen JK. Ureteroscopic management of transitional cell tumors. Scand J Urol Nephrol. 1994;28:153–7.CrossRefPubMed
9.
go back to reference Grasso M, McCue P, Bagley DH. Multiple urothelial recurrences of renal cell carcinoma after initial diagnostic ureteroscopy. J Urol. 1992;147:1358–60.CrossRefPubMed Grasso M, McCue P, Bagley DH. Multiple urothelial recurrences of renal cell carcinoma after initial diagnostic ureteroscopy. J Urol. 1992;147:1358–60.CrossRefPubMed
10.
go back to reference Shiraishi K, Eguchi S, Mohri J, et al. Role of ureteroscopic biopsy in the management of upper urinary tract malignancy. Int J Urol. 2003;10:627–30.CrossRefPubMed Shiraishi K, Eguchi S, Mohri J, et al. Role of ureteroscopic biopsy in the management of upper urinary tract malignancy. Int J Urol. 2003;10:627–30.CrossRefPubMed
11.
go back to reference Ishikawa S, Abe T, Shinohara N, et al. Impact of diagnostic ureteroscopy on intravesical recurrence and survival in patients with urothelial carcinoma of the upper urinary tract. J Urol. 2010;184:883–7.CrossRefPubMed Ishikawa S, Abe T, Shinohara N, et al. Impact of diagnostic ureteroscopy on intravesical recurrence and survival in patients with urothelial carcinoma of the upper urinary tract. J Urol. 2010;184:883–7.CrossRefPubMed
12.
go back to reference Hendin BN, Streem SB, Levin HS, et al. Impact of diagnostic ureteroscopy on long-term survival in patients with upper tract transitional cell carcinoma. J Urol. 1999;161:783–5.CrossRefPubMed Hendin BN, Streem SB, Levin HS, et al. Impact of diagnostic ureteroscopy on long-term survival in patients with upper tract transitional cell carcinoma. J Urol. 1999;161:783–5.CrossRefPubMed
13.
go back to reference Jeldres C, Sun M, Isbarn H, et al. A population-based assessment of perioperative mortality after nephroureterectomy for upper-tract urothelial carcinoma. Urology. 2010;75:315–20.CrossRefPubMed Jeldres C, Sun M, Isbarn H, et al. A population-based assessment of perioperative mortality after nephroureterectomy for upper-tract urothelial carcinoma. Urology. 2010;75:315–20.CrossRefPubMed
14.
go back to reference Shinagare AB, Fennessy FM, et al. Urothelial cancers of the upper urinary tract: metastatic pattern and its correlation with tumor histopathology and location. J Comput Assist Tomogr. 2011;35:217–22.CrossRefPubMed Shinagare AB, Fennessy FM, et al. Urothelial cancers of the upper urinary tract: metastatic pattern and its correlation with tumor histopathology and location. J Comput Assist Tomogr. 2011;35:217–22.CrossRefPubMed
15.
go back to reference Roupret M, Babjuk M, Comperat E, et al. European guidelines on upper tract urothelial carcinomas: 2013 update. Eur Urol. 2013;63:1059–71.CrossRefPubMed Roupret M, Babjuk M, Comperat E, et al. European guidelines on upper tract urothelial carcinomas: 2013 update. Eur Urol. 2013;63:1059–71.CrossRefPubMed
16.
go back to reference Grahn A, Melle-Hannah M, Malm C, et al. Diagnostic accuracy of computed tomography urography and visual assessment during ureterorenoscopy in upper tract urothelial carcinoma. BJU Int. 2017;119:289–97.CrossRefPubMed Grahn A, Melle-Hannah M, Malm C, et al. Diagnostic accuracy of computed tomography urography and visual assessment during ureterorenoscopy in upper tract urothelial carcinoma. BJU Int. 2017;119:289–97.CrossRefPubMed
17.
go back to reference Hafner C, Knuechel R, Zanardo L, et al. Evidence for oligoclonality and tumor spread by intraluminal seeding in multifocal urothelial carcinomas of the upper and lower urinary tract. Oncogene. 2001;20:4910–5.CrossRefPubMed Hafner C, Knuechel R, Zanardo L, et al. Evidence for oligoclonality and tumor spread by intraluminal seeding in multifocal urothelial carcinomas of the upper and lower urinary tract. Oncogene. 2001;20:4910–5.CrossRefPubMed
18.
go back to reference Luo HL, Kang CH, Chen YT, et al. Diagnostic ureteroscopy independently correlates with intravesical recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma. Ann Surg Onco. 2013;20:3121–6.CrossRef Luo HL, Kang CH, Chen YT, et al. Diagnostic ureteroscopy independently correlates with intravesical recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma. Ann Surg Onco. 2013;20:3121–6.CrossRef
19.
go back to reference Pignot G, Colin P, Zerbib M, et al. Influence of previous or synchronous bladder cancer on oncologic outcomes after radical nephroureterectomy for upper urinary tract urothelial carcinoma. Urol Oncol. 2014;32:23.e1–8.CrossRef Pignot G, Colin P, Zerbib M, et al. Influence of previous or synchronous bladder cancer on oncologic outcomes after radical nephroureterectomy for upper urinary tract urothelial carcinoma. Urol Oncol. 2014;32:23.e1–8.CrossRef
20.
go back to reference Milojevic B, Djokic M, Sipetic-Grujicic S, et al. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma. Urol Oncol. 2013;31:1615–20.CrossRefPubMed Milojevic B, Djokic M, Sipetic-Grujicic S, et al. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma. Urol Oncol. 2013;31:1615–20.CrossRefPubMed
21.
go back to reference Nison L, Rouprêt M, Bozzini G, et al. The oncologic impact of a delay between diagnosis and radical nephroureterectomy due to diagnostic ureteroscopy in upper urinary tract urothelial carcinomas: results from a large collaborative database. World J Urol. 2013;31:69–76.CrossRefPubMed Nison L, Rouprêt M, Bozzini G, et al. The oncologic impact of a delay between diagnosis and radical nephroureterectomy due to diagnostic ureteroscopy in upper urinary tract urothelial carcinomas: results from a large collaborative database. World J Urol. 2013;31:69–76.CrossRefPubMed
22.
go back to reference Jinzaki M, Kikuchi E, Akita H, et al. Role of computed tomography urography in the clinical evaluation of upper tract urothelial carcinoma. Int J Urol. 2016;23:284–98.CrossRefPubMed Jinzaki M, Kikuchi E, Akita H, et al. Role of computed tomography urography in the clinical evaluation of upper tract urothelial carcinoma. Int J Urol. 2016;23:284–98.CrossRefPubMed
23.
24.
go back to reference Cutress ML, Stewart GD, Tudor EC, et al. Endoscopic versus laparoscopic management of noninvasive upper tract urothelial carcinoma: 20-year single center experience. J Urol. 2013;189:2054–60.CrossRefPubMed Cutress ML, Stewart GD, Tudor EC, et al. Endoscopic versus laparoscopic management of noninvasive upper tract urothelial carcinoma: 20-year single center experience. J Urol. 2013;189:2054–60.CrossRefPubMed
25.
go back to reference Hong S, Kwon T, You D, et al. Incidence of benign results after laparoscopic radical nephroureterectomy. JSLS. 2014;e2014:00335. Hong S, Kwon T, You D, et al. Incidence of benign results after laparoscopic radical nephroureterectomy. JSLS. 2014;e2014:00335.
26.
go back to reference Azemar MD, Comperat E, Richad F, et al. Bladder recurrence after surgery for upper urinary tract urothelial cell carcinoma: frequency, risk factors, and surveillance. Urol Oncol. 2011;29:103–36.CrossRef Azemar MD, Comperat E, Richad F, et al. Bladder recurrence after surgery for upper urinary tract urothelial cell carcinoma: frequency, risk factors, and surveillance. Urol Oncol. 2011;29:103–36.CrossRef
27.
go back to reference Kim KH, You D, Jeong IG, et al. Muscle-invasive bladder cancer developing after nephroureterectomy for upper urinary tract urothelial carcinoma. Urol Oncol. 2013;31:1643–9.CrossRefPubMed Kim KH, You D, Jeong IG, et al. Muscle-invasive bladder cancer developing after nephroureterectomy for upper urinary tract urothelial carcinoma. Urol Oncol. 2013;31:1643–9.CrossRefPubMed
28.
go back to reference Ito A, Shintaku I, Satoh M, et al. Prospective randomized phase II trial of a single early intraveiscal instillation of pirarubicin (THP) in the prevention of bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma: the THP Monotherapy Study Group Trial. J Clin Oncol. 2013;31:1422–7.CrossRefPubMed Ito A, Shintaku I, Satoh M, et al. Prospective randomized phase II trial of a single early intraveiscal instillation of pirarubicin (THP) in the prevention of bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma: the THP Monotherapy Study Group Trial. J Clin Oncol. 2013;31:1422–7.CrossRefPubMed
29.
go back to reference Yoo S, You D, Song C, et al. Risk of intravesical recurrence after ureteroscopic biopsy for upper tract urothelial carcinoma: does the location matter? J Endourol. 2017;31:259–65.CrossRefPubMed Yoo S, You D, Song C, et al. Risk of intravesical recurrence after ureteroscopic biopsy for upper tract urothelial carcinoma: does the location matter? J Endourol. 2017;31:259–65.CrossRefPubMed
30.
go back to reference Shigeta K, Kikuchi E, Hagiwara M, et al. The over time conditional survival of intravesical recurrence in upper tract urothelial carcinoma. J Urol. 2017;198:1278–85. Shigeta K, Kikuchi E, Hagiwara M, et al. The over time conditional survival of intravesical recurrence in upper tract urothelial carcinoma. J Urol. 2017;198:1278–85.
Metadata
Title
The diagnostic ureteroscopy before radical nephroureterectomy in upper urinary tract urothelial carcinoma is not associated with higher intravesical recurrence
Authors
Hsiang-Ying Lee
Hsin-Chih Yeh
Wen-Jeng Wu
Jiun-Shiuan He
Chun-Nung Huang
Hung-Lung Ke
Wei-Ming Li
Chien-Feng Li
Ching-Chia Li
Publication date
01-12-2018
Publisher
BioMed Central
Published in
World Journal of Surgical Oncology / Issue 1/2018
Electronic ISSN: 1477-7819
DOI
https://doi.org/10.1186/s12957-018-1411-9

Other articles of this Issue 1/2018

World Journal of Surgical Oncology 1/2018 Go to the issue